InsiderClue
← All stocks

Oric Pharmaceuticals, Inc.

ORIC Net selling
CIK 0001796280 #2271 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$5.52M
$2.95M on a plan · $2.07M straight out of an exercise
Sold at will
$496.62K
3 of 15 sales
Net
−$5.52M
−$496.62K against sales at will

By person

6 insiders · 19 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Chacko Jacob
PRESIDENT AND CEO
—
$3.17M (5) scheduled
−$3.17M
581,711
0.5612%
$7.96M
−21.3%
Piscitelli Dominic
Chief Financial Officer
—
$2.01M (4) scheduled
−$2.01M
69,828
0.0674%
$955.66K
−27.3%
Heyman Richard A.
Director
—
$241.49K (5) scheduled
−$241.49K
244,972
0.2363%
$3.35M
+7.1%
Multani Pratik S
Chief Medical Officer
—
$97.13K (1)
−$97.13K
68,149
0.0657%
$932.68K
+98.4%
Kunkel Lori Anne
Director
—
—
—
84,200
0.0812%
$1.15M
+310.7%
You Angie
Director
—
—
—
28,000
0.0270%
$383.21K
—

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Heyman Richard A.
6 Jul 2026
Director
Sold on a plan indirect
300
$12.00
$3.60K
Heyman Richard A.
16 Jan 2026
Director
Sold on a plan indirect
3,200
$12.00
$38.41K
Heyman Richard A.
16 Jan 2026
Director
Sold on a plan
3,500
$12.00
$42.02K
Chacko Jacob
6 Oct 2025
PRESIDENT AND CEO
Sold on a plan
37,461
$12.32
$461.52K
Chacko Jacob
1 Oct 2025
PRESIDENT AND CEO
Sold on a plan
53,001
$12.05
$638.81K
Chacko Jacob
30 Sep 2025
PRESIDENT AND CEO
Sold on a plan
34,538
$12.01
$414.75K
Chacko Jacob
22 Sep 2025
PRESIDENT AND CEO
Sold on a plan
125,000
$10.80
$1.35M
Show all 19 transactions →

What was left out

Form 4 filings counted 23
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 5
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 334,166
History held since 27 Apr 2020